FindMyKOL
Clinical trialNCT04933812CompletedInterventional

EngagINg the COmmunity to Reduce Preterm Birth Via Adherence To an Individualized Prematurity Prevention Plan

NCT04933812 is an interventional trial sponsored by Duke University. As of 21 Nov 2026, it is completed. It studies Preterm Birth. The registry lists an enrollment of 31 participants at 1 site in 1 country. The registry lists a start date of 21 Jun 2021 and a primary completion date of 14 Oct 2022.

SponsorDuke University →Enrollment31Preterm Birth
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT04933812
FieldValue
Registry IDNCT04933812
StatusCompleted
Study typeInterventional trial
Lead sponsorDuke University
Enrollment31
Registered sites1
Countries1
ConditionsPreterm Birth
Start21 Jun 2021
Primary completion14 Oct 2022
Study completion14 Oct 2022
Last update posted4 Nov 2024

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine if INCORPorATe IP3 is feasible prior to a larger trial focused on determining efficacy. Feasibility will be measured using the RE-AIM framework4: Reach or Participation (Primary Outcome): (a) percent of eligible participants who are successfully recruited and attend at least one group session; Effectiveness: retention rate in the intervention; Implementation: fidelity to the intervention protocol; Maintenance: intervention sustainability based on continued engagement from the participants.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

North Carolina, United States1 site
  • Duke University

    Durham

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth Carolina: 1 siteNC1South CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT04933812

Each answer restates registry values shown on this page.

What is NCT04933812?

NCT04933812 is an interventional trial sponsored by Duke University. It studies Preterm Birth.

Who leads NCT04933812?

The registry names Sarahn Wheeler, MD (principal investigator, Duke University) as the overall official.

Where does NCT04933812 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT04933812 end?

The registry lists a primary completion date of 14 Oct 2022 and a study completion date of 14 Oct 2022. The sponsor last updated the record on 4 Nov 2024.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.